Researchers emphasized that the benefits of the vaccine still far outweigh the risks. 

An estimated 1.2 million additional patients are now candidates for the company's small CardioMEMs HF monitor. 

10-year data from the ROOBY study found that there was little difference in outcomes between the two forms of heart bypass surgery. 

The public comment period for these recommendations ends on March 21.

The FDA has already approved one of the medications, with a decision on another expected by the end of April. 

The solution, which gained FDA clearance in November 2021, is now being used by specialists at the University of California San Diego Health.

The two single-use devices are now approved for the treatment of pediatric AVNRT.

Severe financial stress was associated with a 61% increase in 180-day mortality risk in individuals following acute myocardial infarction.